Dialyzer Reprocessing Unit for Patient with End-Stage Renal Disease


  • Hina Abbasi Sir Syed University of Engineering & Technology, Karachi Pakistan
  • Sania Tanvir Sir Syed University of Engineering & Technology, Karachi Pakistan
  • Marium Raziq Sir Syed University of Engineering & Technology, Karachi Pakistan
  • Shahzad Nasim The Begum Nusrat Bhutto Women University, Sukkur
  • Sidra Abid Syed Sir Syed University of Engineering & Technology, Karachi Pakistan
  • Rafay Sharif Sir Syed University of Engineering & Technology, Karachi Pakistan
  • Syed Jamal Hyder Zaidi IQRA University, Karachi


DRU, hydrogen peroxide, artificial kidney, microcontroller, renal


The purpose of this studies article is to broaden a low-price dialyzer reprocessing unit (DRU) prototype which could easy and sanitise hemodialysis dialyzers. Hemodialysis is a crucial scientific technique that enables patients with quit-level kidney disorder or renal failure eliminate waste products from their blood. Often known as a "artificial kidney," the dialyzer is vital to blood filtration. There are kinds of dialysis machines: disposable and reusable. The reusable kind can best be used as much as 16 times. Such machines are high-priced to import, which makes it difficult for people in need to gain them. Thus, the goal of this studies is to create a low-cost DRU for cleaning and disinfecting dialyzers on the way to assure their efficacy and reduce expenses. Water, hydrogen peroxide, and other substances are managed through the DRU the use of a microprocessor.


Agodoa LY, Wolfe RA, Port FK. Reuse of dialyzers and clinical outcomes: Fact or fiction. American Journal of Kidney Diseases. 1998;32(6).

Argyropoulos C, Roumelioti M-E, Sattar A, Kellum JA, Weissfeld L, Unruh ML. Dialyzer reuse and outcomes of high flux dialysis. PLOS ONE. 2015;10(6).

ANEES MUHAMAMD. Comparison of awareness about nephrology and kidney diseases amongst doctors: In istitutes with and without nephrology departments. Pakistan Journal of Medical Sciences. 2014;30(4).

Blagg CR. The early history of dialysis for chronic renal failure in the United States: A view from Seattle. American Journal of Kidney Diseases. 2007;49(3):482–96.

Bond TC, Nissenson AR, Krishnan M, Wilson SM, Mayne T. Dialyzer reuse with peracetic acid does not impact patient mortality. Clinical Journal of the American Society of Nephrology. 2011;6(6):1368–74.

Dhrolia MF, Qureshi R, Nasir K, Imtiaz S, Ahmad A. Comparison of total direct cost of conventional single use and mechanical reuse of dialyzers in patients of end-stage renal disease on maintenance haemodialysis: A single center study. Saudi Journal of Kidney Diseases and Transplantation. 2016;27(4):774.

Chuang F-R, Lee C-H, Chang H-W, Lee C-N, Chen T-C, Chuang C-H, et al. A quality and cost-benefit analysis of dialyzer reuse in haemodialysis patients. Renal Failure. 2008;30(5):521–6.

Denny GB, Golper TA. Does hemodialyzer reuse have a place in current ESRD care: “to be or not to be?” Seminars in Dialysis. 2014;27(3):256–8.

Feldman HI, Bilker WB, Hackett M, Simmons CW, Holmes JH, Pauly MV, et al. Association of dialyzer reuse and hospitalization rates among haemodialysis patients in the US. American Journal of Nephrology. 1999;19(6):641–8.

Galvao TF, Silva MT, Araujo ME, Bulbol WS, Cardoso AL. Dialyzer reuse and mortality risk in patients with end-stage renal disease: A systematic review. American Journal of Nephrology. 2012;35(3):249–58.

Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN. Analysis of the association of dialyzer reuse practices and patient outcomes. American Journal of Kidney Diseases. 1994;23(5):692–708.

Kimmel PL, Mishkin GJ. Dialyzer reuse and the treatment of patients with end-stage renal disease by haemodialysis. Journal of the American Society of Nephrology. 1998;9(11):2153–6.

Köse K, Doğan P, Gündüz Z, Düşünsel R, Utaş C. Oxidative stress in hemodialyzed patients and the long-term effects of dialyzer reuse practice. Clinical Biochemistry. 1997;30(8):601–6.

Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LYC, Jones C, et al. Mortality risk by Hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. American Journal of Kidney Diseases. 2001;37(2):276–86.

Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases. 2002;40(3):611–22.

Ribeiro IC, Roza NA, Duarte DA, Guadagnini D, Elias RM, Oliveira RB. Clinical and microbiological effects of dialyzers reuse in haemodialysis patients. Brazilian Journal of Nephrology. 2019;41(3):384–92.

Saeed F, Sardar M, Rasheed K, Naseer R, Epstein RM, Davison SN, et al. Dialysis decision making and preferences for end-of-life care: Perspectives of Pakistani Patients Receiving Maintenance Dialysis. Journal of Pain and Symptom Management. 2020;60(2):336–45.

Collins AJ, Liu J, Ebben JP. Dialyser reuse-associated mortality and hospitalization risk in incident Medicare haemodialysis patients, 1998-1999. Nephrology Dialysis Transplantation. 2004;19(5):1245–51.

Duong CM, Olszyna DP, Nguyen PD, McLaws M-L. Challenges of Haemodialysis in Vietnam: Experience from the first standardized district dialysis unit in Ho Chi Minh City. BMC Nephrology. 2015;16(1).

Okechukwu CN, Orzol SM, Held PJ, Pereira BJG, Agodoa LYC, Wolfe RA, et al. Characteristics and treatment of patients not reusing dialyzers in reuse units. American Journal of Kidney Diseases. 2000;36(5):991–9.

Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney International. 1999;55(3):1081–90.

Rao M, Guo D, Jaber BL, Sundaram S, Cendoroglo M, King AJ, et al. Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in haemodialysis patients. Kidney International. 2004;65(2):682–91.

Rizvi SA, Naqvi SA, Zafar MN, Akhtar SF. A kidney transplantation model in a low-resource country: An experience from Pakistan. Kidney International Supplements. 2013;3(2):236–40.

Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: Burden of disease and management issues. Kidney International. 2003;63.

Shusterman NH, Feldman HI, Wasserstein A, Strom BL. Reprocessing of hemodialyzers: A critical appraisal. American Journal of Kidney Diseases. 1989;14(2):81–91.

Vinhas J, Santos JP. Haemodialyser Reuse: Facts and fiction. Nephrology Dialysis Transplantation. 2000;15(1):5–8.

Westhuyzen J, Foreman K, Battistutta D, Saltissi D, Fleming SJ. Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in haemodialysis patients. American Journal of Nephrology. 1992;12(1-2):29–36.